Related Experiment Video
Updated: Jun 15, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
[Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency]
Christian Schwartz1, Valentin Le Douce, Thomas Cherrier
1Inserm Unité 575 Physiopathologie du système nerveux central, Institut de virologie, Strasbourg, France. schwartz.christian@iutlpa-strasbg.fr
The introduction of the highly active antiretroviral therapy (HAART) in 1996 has greatly extended survival and raised hopes for the eradication of HIV-1. Unfortunately, the optimism declined by revealing the existence of latent HIV-1 reservoirs in cells targeted by the virus. The long-lived HIV-1 reservoirs constitute a major obstacle to the eradication of HIV-1. Understanding the molecular mechanisms of virus latency is essential for efficient therapeutic intervention against the virus.
The introduction of the highly active antiretroviral therapy (HAART) in 1996 has greatly extended survival and raised hopes for the eradication of HIV-1. Unfortunately, the optimism declined by revealing the existence of latent HIV-1 reservoirs in cells targeted by the virus. The long-lived HIV-1 reservoirs constitute a major obstacle to the eradication of HIV-1. Understanding the molecular mechanisms of virus latency is essential for efficient therapeutic intervention against the virus.
Related Concept Videos
Size and Structure of Viral Genomes
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Viruses with RNA Genomes

